Being more like Coca-Cola takes about 10 days out of GSK’s pharma supply chain

In the last 6 months, GSK has been “simplifying the manufacturing footprint” to align that footprint more tightly to the three main businesses: Vaccines, Pharma and Consumer. Creating a single end-to-end supply chain, much like you would find in any of the major Fast Moving Consumer Goods (FMCG) companies around the world allows the company to drive the speed of response, drive the costs lower and particularly to drive cash and the working capital out of the process.

Read the Story